The global sales of orthopedic consumables are estimated to be worth USD 44.0 billion in 2024 and are anticipated to reach a value of USD 60.9 billion by 2034. Sales are projected to rise at a CAGR of 3.3% over the forecast period between 2024 and 2034. The revenue generated by orthopedic consumables in 2023 was USD 42.6 billion.
The demand for orthopedic consumables is on the rise, as these products play a crucial role in facilitating the application of various cements, and rods for effective orthopedic treatments. To improve production efficiency and offer specialized, effective solutions, orthopedic consumables manufacturers are progressively implementing cost-effective tactics that aid in their market expansion.
For the treatment of bone injuries, orthopedic consumables such as burrs, drill bits, pins, K-wires, and saw blades are crucial. The demand for these items is anticipated to soar because to the rise in injuries worldwide, especially those affecting the upper and lower extremities.
Global Orthopedic Consumables Industry Assessment
| Attributes | Key Insights |
|---|---|
| Historical Size, 2023 | USD 42.6 billion |
| Estimated Size, 2024 | USD 44.0 billion |
| Projected Size, 2034 | USD 60.9 billion |
| Value-based CAGR (2024 to 2034) | 3.3% |
The increase in sports-related injuries, which often require more complicated treatment approaches that may include damage to the peripheral bone structure, is leading to increased utilization of orthopedic consumables. Utilization of orthopedic consumables for surgeries enables surgical planning for orthopedic procedures, lending to its use in diagnosing and treating injuries and illnesses related to bone.
The increasing incidence of joint dislocation cases is expected to drive the demand for orthopedic surgeries and consumables. The use of orthopedic consumables in joints and hip replacements is also expected to drive additional utilization of orthopedic consumables in the global market.
In orthopedic surgery, different technologies are enhancing both the precision and effectiveness of interventional processes ranging from robotic assistance to less invasive procedures. This implies that many advanced surgical tools are required to achieve better surgical results and minimize recovery periods.
Robotic-assisted surgeries and 3D-printed implants, for example, are advancing the standard of orthopedic surgery that includes the utilization of consumables specifically drill bits, saw blades, and fixation pins, thereby expanding the adaptability of these products to procedures outside of traditional orthopedic operations.
The surge in demand for personalized solutions of orthopedic consumables via these service innovations will further enhance demand as healthcare providers seek to improve clinical outcomes for patients and their patient experience.
Explore FMI!
Book a free demo
The table below compares the compound annual growth rate (CAGR) for the global orthopedic consumables market from 2023 to 2024 during the first half of the year. This overview highlights key changes and trends in revenue growth, offering valuable insights into market dynamics.
H1 covers January to June, while H2 spans July to December. In the first half (H1) of the decade from 2023 to 2033, the business is predicted to surge at a CAGR of 4.2%, followed by a slightly lower growth rate of 3.7% in the second half (H2) of the same decade.
| Particular | Value CAGR |
|---|---|
| H1 | 4.2% (2023 to 2033) |
| H2 | 3.7% (2023 to 2033) |
| H1 | 3.3% (2024 to 2034) |
| H2 | 2.8% (2024 to 2034) |
Moving into the subsequent period, from H1 2024 to H2 2034, the CAGR is projected to decrease slightly to 3.3% in the first half and projected to lower at 2.8% in the second half. In the first half (H1) the market witnessed a decrease of 90 BPS while in the second half (H2), the market witnessed a decrease of 90 BPS.
The Rising Prevalence of Osteoarthritis is Significantly Contributing to the Growing Demand for Orthopedic Consumables across Healthcare Markets.
One of the major factors driving the market growth is the rising prevalence of musculoskeletal conditions like osteoarthritis across the globe. The incidence of osteoarthritis is higher among older age and female patient populations.
In 2019, according to the WHO 2023, 528 million people were living with osteoarthritis across the world, with an increase of 113% from 1990. About 73% of the symptomatic people were aged over 55 years and 60% of them were females. Out of all the joints affected, the knee was affected the most joint out of all three osteoarthritis knees, hip, and hand, with a total of 365 million patients.
Also, symptomatic knee [183 million] osteoarthritis affected more people than hip [115 million] and hand [38 million] symptomatic sites. Continuing the same trend, the patient pool in the future elderly is set to increase and is expected to increase the need for successful therapeutic measures, thus benefiting the orthopedic consumables market.
Given the above-mentioned burden of the active adult osteoarthritis population and the pain control issues, many people would ultimately get surgery, hence elevating demand in the overall demand for orthopedic consumables. Therefore, the Global Osteoarthritis Burden drives the growth of the orthopedic consumables market.
Growing Demand for Single-Use Solutions Presents Market Opportunity in Orthopedic Consumables
The orthopedic consumables market is set to have substantial growth potential as a result of the greater emphasis on single-use devices. Products such as these provide increased safety and convenience to healthcare providers and patients alike.
A greater emphasis on infection control and the elimination of cross-contamination risk has cemented single-use consumables as a favorable solution during surgical procedures. This paradigm shift is vital in orthopedic surgeries due to the importance of sterile conditions to ensure a favorable patient prognosis.
The potential for demand for single-use consumables and new entrants into the orthopedic consumables space represent important market opportunities. Several manufacturers see the market opportunity for developing disposable consumables that are constructed to the required standards of safety within modern health care.
The trend toward single-use sterile surgical supplies is also fostering new economic and product innovations as manufacturers are scorning the balance between reliability and low-cost consumables in terms of construction to the needs of orthopedic surgeons and surgical centers. Healthcare systems are expected to favor single-use orthopedic consumables, driving firms to develop and customize these devices for orthopedic surgeries.
Resorbable and Biocompatible Materials Transforming and Creating New Opportunities for the Orthopedic Consumables Market
A notable new market opportunity for orthopedic consumables exists in resorbable and biocompatible materials. Due to advancements in biomaterials, there is a growing interest in consumables including screws, pins, and plates that would degrade and be replaced by tissue once they have fulfilled their mechanical function.
This is especially critical to orthopedic surgeries in pediatric and young patients, as these devices would otherwise need to be removed via a second surgery if they were made from metal.
Resorbable materials lead to better patient outcomes while decreasing healthcare costs due to the non-necessity for secondary procedures.
The trend is supported by materials science breakthroughs in the field of poly(α-hydroxy acid) polymers, as many of the polymeric resorbable materials used nowadays, such as polylactic acid (PLA) and polyglycolic acid (PGA) have been shown to possess excellent biocompatibility, mechanical strength, and controlled degradation rates.
Moreover, resorbable soft tissue orthopedic devices such as screws, pins, and plates meet society's demand for more sustainable healthcare options for improved environmental health and diminished long-term use of non-degradable metals. The developers of the medical orthopedic consumption market with traditional resorbable materials are faced with a combination of clinical, economic, and sustainable benefits.
Regulatory and Compliance as Major Barrier to Growth in the Orthopedic Consumables Market
A significant constraint within the orthopedic consumables market is the increasing regulatory uncertainty often arising from the complex and rapidly evolving regulatory framework related to product approval and/or appeals, and compliance with international standards.
Orthopedic implants and consumables are multisystem, high risk devices, often utilizing novel materials, or complex designs. In short, they are often defined by complex manufacturing processes that require companies to conform to rigid regulatory requirements dictated by extension groups such as the USA FDA, the European Medicines Agency (EMA) or other global co-contributors.
For example, the FDA classifies many orthopedic consumables within the Class III device scope, thus they effectively require premarket approval that's typically supported by significant clinical data and strong evidence of benefit/risk ratios, which can cause significant delays in product approval.
This issue is compounded by variable regulatory standards across regions and markets. Organizations also have to comply with different rules of compliance depending on the market numerous players find this to cause further delays for new products and market uptake.
Moreover, once commercially available if an organization fails to comply, or there is a notifiable incident following a commercial sale, organizational recalls or other forms of litigation response can be overwhelming.
Therefore, these bespoken regulatory burdens are often difficult and burdensome for players involved in orthopedic consumables market and do create significant barriers to entry and/or long-term market countries in new orthopedic consumables.
The global orthopedic consumables industry recorded a CAGR of 2.8% during the historical period between 2019 and 2023. The growth of orthopedic consumables diagnostics industry was positive as it reached a value of USD 60.9 billion in 2034 from USD 44.0 billion in 2024.
Over time, the orthopedic consumables marketplace has undergone structural change, like many of the other areas of health care due to rising healthcare costs, increasing aging and demographic change, and advances in technology. Advances in materials and technology in consumable products (suture anchors, plates, screws, etc.) are designed and manufactured have driven the biggest change in orthopedic treatment.
The line between traditional surgical techniques and modern surgical techniques used for care is rapidly diminishing, as developers integrate biocompatible and resorbable substrates into previously surgical video-guided methods, to provide a safer means of care for patients.
Many advances in the surgical field utilize roboskills, like three-dimensional printing, to produce tailored implants that resolve surgical conditions that were challenging to address. Additionally, we have seen an increase in the use of minimally invasive surgical techniques that, in tandem with the advanced substrates, have increased the demand for consumable products that are more sophisticated and encompass simpler designs in all variables of surgical delivery.
Increased awareness of injuries related to sports, especially in youth, has added to a rise in the utilization of orthopedic consumables related to reconstructive surgeries.
The orthotic peripheral marketplace has also observed an emphasis on sustainable, cost-effective products with minimal direct post-surgical use. Development of cost-effective orthopedic products and consumables has accelerated to replace the need for alternate or post-operative surgical procedures, enabling care systems to find reduced costs.
This is related to regulatory pathways that have seen heightened levels of administrative files with exit documents for safety, biocompatibility, and effectiveness six months to two years later also reducing other alternate care commitments.
The globalization of healthcare practices has also provided opportunities for access and use in multiple arenas of healthcare an organized orthopedic marketplace; however, new opportunities have also confirmed challenges with regional differences with policy changes and developing and providing regulation of burgeoning global practice potentials and healthcare infrastructure issues.
Tier 1 companies are the major companies as they hold a 25.7% share worldwide. These companies have large product portfolios and a high production capacity. Companies with the diverse portfolio also has global presence along with strong research and development capabilities.
Their vast range of applications and innovative solutions help them maintain industry leadership. Prominent companies within tier 1 include ConMed Corporation, Stryker Corporation and Johnson & Johnson
Tier 2 companies are relatively smaller as compared with tier 1 players. The tier 2 companies hold a share of 29.7% worldwide. Firms in this tier offer a wide range of orthopedic consumables, with a particular emphasis on minimally invasiveness. Their devotion to innovation and diverse product lines contributes to their prominent position. Key Companies under this category include Zimmer Biomet, Medtronic plc., 3M Company, and DSM Biomedical.
Compared to Tiers 1 and 2, Tier 3 companies offer orthopedic consumables, but with smaller revenue spouts and less influence. These companies mostly operate in one or two countries and have a limited customer base. Tier 3 companies, although, smaller are essential for the market. The companies such as Wright Medical Group, Inc., Bio Tek Instruments, Inc. and other fall under this category.
The section below covers the industry analysis for the orthopedic consumables market for different countries. Market demand analysis on key countries in several regions of the globe, including North America, Asia Pacific, Europe, and others, is provided. The United States is anticipated to remain at the forefront in North America, with a CAGR of 1.0% through 2034. In Asia Pacific, India is projected to witness the highest CAGR in the market of 3.7% by 2034.
| Countries | Value CAGR (2024 to 2034) |
|---|---|
| USA | 1.0% |
| Germany | 1.2% |
| India | 3.7% |
| UK | 1.2% |
| China | 3.3% |
| Spain | 1.9% |
The USA dominates the global market with high share in 2023. The USA is expected to exhibit a CAGR of 1.0% throughout the forecast period (2024 to 2034).
The United States encompasses a considerable portion of the global orthopedic consumables, propelled by the increasing adoption of sophisticated orthopedic surgeries, particularly interventional procedures. A foremost catalyst of this trend is the prominently developed healthcare infrastructure that engenders the development of advanced surgical procedures using robotic-assisted and minimally invasive procedures.
The USA healthcare system is distinguished by relatively broad-based access to advanced specialty orthopedic care, which is highly localized in leading hospital and surgical center markets, allowing the surgical community to use advanced solutions to musculoskeletal disorders of bone, joint, and spine.
Orthopedic surgeons are becoming more and more receptive to interventional orthopedic surgeries and procedures, like arthroscopy and spine interventions, because of the positive results, which include shorter recovery times following surgery, lower rates of morbidity from complications, and improved outcomes over time. This leads to an increased demand for consumables, like sutures, bone graft alternatives, and fixation devices.
In 2023, Germany held a dominant revenue in the Western Europe market and is expected to grow with a CAGR of 1.2%. Germany is driven mainly by an emphasis on the use of disposable devices and systems in surgical procedures.
The increased acceptance of disposable devices in surgical procedures such as single-use sutures, sterile drapes, and wound care materials has developed based on considerations for infection control, operational efficiency, and cost-effective measures for orthopedic surgeries.
Disposable devices offer hospitals less risk of cross-contamination during the surgery, which provides for reduced length of stay and eliminates the need for sterilization, which is in alignment with Germany's diligent protocols on safety in health care. Due to the shorter recovery times and decreased complication rates associated with these less invasive techniques, orthopedic surgeons in Germany are increasingly employing consumables made for them.
Germany's orthopedic consumables market is anticipated to grow quickly as demand increases for safer and more effective surgical treatments, especially in the areas of trauma and reconstructive procedures.
China occupies a leading value share in East Asia market in 2023 and is expected to grow with a CAGR of 3.3% during the forecasted period.
China's orthopedic consumables market is growing rapidly due to access to healthcare and increasing orthopedic product applications within surgery. One of the most influential factors is the strong domestic manufacturing base. Chinese manufacturers produce continuously developed, high-quality consumables at ideological, competitive prices.
Certain local companies are satisfying domestic demand and taking the next steps to develop cheaper alternatives to imported consumables in the global market. As a consequence, product acceptance has been widespread throughout Chinese hospitals and clinics, especially in regions that are experiencing a rise in orthopedic case volumes.
Healthcare infrastructure is expanding, supported by the government, leading to an increase in orthopedic surgery -specifically joint replacements and trauma cases. Increased cases of orthopedic surgeries are evident with an aging population, subsequent to increasing sports injuries and degenerative conditions. In addition, China's continued demand and prevalent manufacturing capacity facilitate the orthopedic consumables to rise.
The section contains information about the leading segments in the industry. Based on product type, the wound-management orthopedic consumables is expected to account 38.5% of the global share in 2024.
| Product Type | Wound-Management Orthopedic Consumables |
|---|---|
| Value Share (2024) | 38.5% |
By product type, wound-management orthopedic consumables is expected to hold a share of 38.5% in 2024. Wound-management orthopedic consumables are leading in the market, as these products are critical to post-operative care. These products act by preventing infections, controlling bleeding, and offering rapid healing along with considerably reducing the scarring post-orthopedic surgeries.
Antimicrobial dressings along with advanced wound care technology including bioactive products such as hydrogels have considerably enhanced the patient outcome, thus influencing the demand for them. With the growing complexity of orthopedic procedures, there is increasing demand for individualized trauma and elective surgery consumables, attributed to their higher demand as compared to other product types.
| By End User | Hospitals |
|---|---|
| Value Share (2024) | 61.6% |
Hospitals will account for 61.6% of the indication segment in 2024, and exhibit the highest CAGR in the forecast period. Hospitals would continue to lead the end user segment as they perform a considerable number of orthopedic surgeries in their facilities. Hospitals offer all-encompassing care with a well-developed infrastructure, modern technological tools, and effective treatment due to the presence of skilled surgeons and high patient inflow.
Hospitals also procure new consumables through their procurement facilities post-approval from respective authority for use in surgeries, thus contributing to a larger share for consumables enterprises. Significant numbers of trauma centers and elective surgery centers are based in the hospital premises which also drive the demand for orthopedic consumables.
The orthopedic consumables market is highly competitive, with key players like Stryker, Zimmer Biomet, and Johnson and Johnson dominating through product innovation, mergers, and acquisitions. Companies focus on advanced technologies, such as robotic-assisted surgeries, and expanding portfolios to meet the growing demand for minimally invasive procedures and joint replacements.
Recent Industry Developments in Orthopedic Consumables Market
The global orthopedic consumables industry is projected to witness CAGR of 3.3% between 2024 and 2034.
The global orthopedic consumables industry stood at USD 42.6 billion in 2023.
The global orthopedic consumables industry is anticipated to reach USD 60.9 billion by 2034 end.
China is expected to show a CAGR of 3.3% in the assessment period.
The key players operating in the global orthopedic consumables industry include ConMed Corporation, Stryker Corporation, Johnson & Johnson, Zimmer Biomet, Medtronic plc., 3M Company, DSM Biomedical, Wright Medical Group, Inc. and Bio Tek Instruments, Inc.
In terms of service, the industry is divided into wound-management orthopedic consumables, surgical orthopedic consumables and others.
In terms of end user, the industry is segregated into hospitals, ambulatory surgical centers, clinics and others
Key countries of North America, Latin America, East Asia, South Asia & Pacific, Western Europe, Eastern Europe Middle East and Africa (MEA) have been covered in the report.
Orthopedic Consumables Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
